Registered number |
Registered number: | |||||||
Balance Sheet | |||||||
as at |
|||||||
Notes | 2024 | 2023 | |||||
£ | £ | ||||||
Fixed assets | |||||||
Investments | 4 | ||||||
Current assets | |||||||
Debtors | 5 | ||||||
Creditors: amounts falling due within one year | 6 | ( |
( |
||||
Net current liabilities | ( |
( |
|||||
Net assets | |||||||
Capital and reserves | |||||||
Called up share capital | |||||||
Capital redemption reserve | |||||||
Profit and loss account | |||||||
Shareholders' funds | |||||||
Alan Poole | |||||||
Director | |||||||
Approved by the board on |
|||||||
Notes to the Accounts | ||||||||
for the year ended |
||||||||
1 | Accounting policies | |||||||
Basis of preparation | ||||||||
Investments | ||||||||
Creditors | ||||||||
Share based payments | ||||||||
Equity-settled share-based payments are measured at fair value at the date of grant by reference to the fair value of the equity instruments granted using the Black Scholes model. The fair value determined at the grant date is expensed on a straight-line basis over the vesting period, based on the estimate of shares that will eventually vest. A corresponding adjustment is made to equity. The expense in relation to options over the company's shares granted to employees of a subsidiary is recognised by the company as a capital contribution, and presented as an increase in the company's investment in the subsidiary. Cancellations or settlements are treated as acceleration of vesting and the amount that would have been recognised over the remaining vesting period is recognised immediately. |
||||||||
2 | Employees | 2024 | 2023 | |||||
Number | Number | |||||||
Average number of persons employed by the company | ||||||||
3 | Share based payments | |||||||
The company has an employee share option scheme to enable employees of the subsidiary company to acquire fully paid C ordinary shares in the capital of the company under the relevant terms and conditions of the scheme. The scheme operates over a term not exceeding 10 years. The number of shares over which options are granted was 3,500 at the start of the year and at the balance sheet date. At the start of the year, the weighted average exercise price of options granted was £0.01 with 4 participants. Options over 1500 shares at an average exercise price of £0.01 were forfeited by 2 participants during the year. Options over 1500 shares at an average exercise price of £19.14 were awarded to 4 participants during the year. At the balance sheet date the total number of shares under option was 3,500, with 6 potential participants. The weighted average exercise price of options outstanding at the year end was £8.21. An expense of £nil was recognised in the year. |
||||||||
4 | Investments | |||||||
Investments in | ||||||||
subsidiary | ||||||||
undertakings | ||||||||
£ | ||||||||
Cost | ||||||||
At 1 March 2023 | ||||||||
At 29 February 2024 | ||||||||
Historical cost | ||||||||
At 1 March 2023 | 145,010 | |||||||
At 29 February 2024 | 145,010 | |||||||
5 | Debtors | 2024 | 2023 | |||||
£ | £ | |||||||
Other debtors | ||||||||
6 | Creditors: amounts falling due within one year | 2024 | 2023 | |||||
£ | £ | |||||||
Amounts owed to group undertakings and undertakings in which the company has a participating interest | ||||||||
Other creditors | ||||||||
7 | Other information | |||||||
Cake Positive Limited is a private company limited by shares and incorporated in England. Its registered office is: | ||||||||
2-4 The Byres | ||||||||
Wicklesham Lodge Farm | ||||||||
Faringdon | ||||||||
SN7 7PN |